Search research articles

ABOUT JoVE

Overview Leadership Blog JoVE Help Center

AUTHORS

Publishing Process Editorial Board Scope & Policies Peer Review FAQ Submit

LIBRARIANS

Testimonials Subscriptions Access Resources Library Advisory Board FAQ

RESEARCH

JoVE Journal Methods Collections JoVE Encyclopedia of Experiments Archive

EDUCATION

JoVE Core JoVE Business JoVE Science Education JoVE Lab Manual Faculty Resource Center Faculty Site

Terms & Conditions of Use

Related Concept Videos

Pharmacogenetics of Phase I Enzymes: Cytochrome P450 Isozymes

Pharmacogenetics of Phase I Enzymes: Cytochrome P450 Isozymes

Cytochrome P450 (CYP450) enzymes are a superfamily of heme-containing monooxygenases that play a pivotal role in Phase I drug metabolism by catalyzing oxidation and reduction reactions.These enzymes transform lipophilic xenobiotics into more hydrophilic metabolites, facilitating subsequent Phase II conjugation and eventual excretion. The CYP450 family is classified into families (e.g., CYP1–CYP3) and subfamilies (e.g., CYP2A, CYP2C), based on amino acid sequence homology.CYP450...

Pharmacogenetics of Drug Metabolism: Overview

Pharmacogenetics of Drug Metabolism: Overview

Genetic polymorphism in drug metabolism is crucial to the inter-individual variability observed in drug responses. Drug metabolism primarily involves the chemical modification of drugs and other xenobiotics to enhance their elimination by increasing their polarity. Two main classes of enzymes mediate this biotransformation process: Phase I enzymes, primarily cytochrome P450s, catalyze oxidation and reduction reactions, while other enzymes, such as esterases, mediate hydrolysis, and Phase II...

Pharmacogenomics: Identification of New Drug Targets

Pharmacogenomics: Identification of New Drug Targets

Advances in genomics have profoundly influenced drug discovery by increasing both the speed and accuracy of pharmaceutical development. Pharmacogenomics, which examines how genetic variation influences drug response, facilitates the identification of novel therapeutic targets and enables patient stratification for personalized treatment. These strategies contribute to improved drug efficacy, minimized adverse effects, and more efficient clinical trial design.Mapping genetic differences...

Single Nucleotide Polymorphisms-SNPs

Single Nucleotide Polymorphisms-SNPs

A single nucleotide polymorphism or SNP is a single nucleotide variation at a specific genomic position in a large population. It is the most prevalent type of sequence variation found in the human genome. Point mutations that occur in more than 1% of the population qualify as SNPs. These are present once every 1000 nucleotides on an average in the human genome. Replacement of a purine with another purine (A/G) or a pyrimidine with another pyrimidine (C/T) is known as a transition. In contrast,...

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by

Same author

[Comparative analysis of prognostic performance among different lymph node staging systems in gastric cancer].

Zhonghua zhong liu za zhi [Chinese journal of oncology]·2026

Same author

CaSR Activation Triggers Mandibular Overgrowth in Familial Mandibular Prognathism Patients and Mice.

Journal of dental research·2025

Same author

[Impact of outpatient services utilization of heart failure patients on hospitalization rate and its threshold effect: Taking patients with Urban Employee Basic Medical Insurance in Zhejiang Province as an example].

Beijing da xue xue bao. Yi xue ban = Journal of Peking University. Health sciences·2025

Same author

[Current management status of real-world studies in medical institutions in China].

Zhonghua liu xing bing xue za zhi = Zhonghua liuxingbingxue zazhi·2025

Same author

[Expedited program and utilization for anticancer drug approval in China and the United States].

Zhonghua zhong liu za zhi [Chinese journal of oncology]·2024

Same author

[Role of neoadjuvant rectal score in prognosis and adjuvant chemotherapy decision-making in locally advanced rectal cancer following neoadjuvant short-course radiotherapy and consolidation chemotherapy].

Zhonghua zhong liu za zhi [Chinese journal of oncology]·2024

Search research articles

Related Experiment Video

Updated: Apr 27, 2026

Candidate Gene Testing in Clinical Cohort Studies with Multiplexed Genotyping and Mass Spectrometry

Candidate Gene Testing in Clinical Cohort Studies with Multiplexed Genotyping and Mass Spectrometry

Published on: June 21, 2018

Establishment of CYP2D6 reference samples by multiple validated genotyping platforms.

H Fang¹, X Liu², J Ramírez²

¹1] Committee on Clinical Pharmacology and Pharmacogenomics, The University of Chicago, Chicago, IL, USA [2] Section of Hematology/Oncology, The University of Chicago, Chicago, IL, USA.

The Pharmacogenomics Journal

|July 2, 2014

Summary

Precise cytochrome P450 2D6 (CYP2D6) genotyping was achieved using multiple methods. This validated genotype-phenotype prediction for drug metabolism, establishing a reference for pharmacogenomic testing.

More Related Videos

Infinium Assay for Large-scale SNP Genotyping Applications

Infinium Assay for Large-scale SNP Genotyping Applications

Published on: November 19, 2013

An Affordable HIV-1 Drug Resistance Monitoring Method for Resource Limited Settings

An Affordable HIV-1 Drug Resistance Monitoring Method for Resource Limited Settings

Published on: March 30, 2014

Related Experiment Videos

Last Updated: Apr 27, 2026

Candidate Gene Testing in Clinical Cohort Studies with Multiplexed Genotyping and Mass Spectrometry

Candidate Gene Testing in Clinical Cohort Studies with Multiplexed Genotyping and Mass Spectrometry

Published on: June 21, 2018

Infinium Assay for Large-scale SNP Genotyping Applications

Infinium Assay for Large-scale SNP Genotyping Applications

Published on: November 19, 2013

An Affordable HIV-1 Drug Resistance Monitoring Method for Resource Limited Settings

An Affordable HIV-1 Drug Resistance Monitoring Method for Resource Limited Settings

Published on: March 30, 2014

Area of Science:

Pharmacogenomics
Drug Metabolism
Genetics

Background:

Cytochrome P450 2D6 (CYP2D6) is a highly polymorphic enzyme crucial for metabolizing many common medications.
Accurate CYP2D6 genotyping is essential for personalized medicine and predicting drug response.

Purpose of the Study:

To develop and validate precise genotyping methods for CYP2D6, including copy number variations.
To establish a correlation between CYP2D6 genotype and enzyme activity (phenotype).
To create a reference resource of characterized samples for quality control in pharmacogenomic testing.

Main Methods:

Application of multiple genotyping techniques and Sanger sequencing for CYP2D6 genotype assignment.
Analysis of endoxifen formation from N-desmethyl-tamoxifen in human liver microsomes to determine phenotype.
Statistical analysis, including rank correlation, to assess genotype-phenotype relationship.

Main Results:

Precise and reproducible CYP2D6 genotypes, including copy numbers, were assigned for 48 HapMap samples.
A significant positive correlation was observed between CYP2D6 genotype-assigned activity score and endoxifen formation rate (r = 0.68, P = 5.3 × 10(-8)).
The results validated the genotype-phenotype prediction accuracy of the developed methodologies.

Conclusions:

The developed CYP2D6 genotyping methods are reliable for precise genotype and copy number determination.
The study successfully linked CYP2D6 genotype to metabolic activity, confirming predictive capabilities.
The characterized HapMap samples provide a valuable reference for assay validation and clinical pharmacogenomic implementation.